Patents by Inventor Akash Mehta

Akash Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250021938
    Abstract: Systems and methods for integrating computer applications is disclosed. A method includes receiving, at a secondary product platform, a first permission check request for a user of a primary client; determining, via a second backend system, whether the user is licensed for the secondary product platform; upon determining the user is not licensed, generating and communicating a second permission check request to a first backend system of a primary product platform; receiving, from the first backend system, an indication the user is associated with a permission maintained and checked via the primary product platform; upon receiving the indication, determining whether the project of the primary product platform is linked to a corresponding space of the secondary product platform associated with a resource; granting access, via the second backend system, to the resource for a current session that will expire at the end of the current session.
    Type: Application
    Filed: October 1, 2024
    Publication date: January 16, 2025
    Applicants: ATLASSIAN PTY LTD., ATLASSIAN US, INC.
    Inventors: Viraj Sinha, Akash Lalwani, Kritika Bahl, Amaresh Dhar Dwivedi, Lisa Panda, Jiangyue Zhu, Bhakti Mehta, Neha Kalekar, Qixiang Zhang
  • Publication number: 20190055509
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Application
    Filed: July 5, 2018
    Publication date: February 21, 2019
    Inventors: John Mark Meacham, Kiranmai Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta
  • Publication number: 20170292106
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 12, 2017
    Inventors: John Mark Meacham, Kiranmai Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta
  • Patent number: 9725709
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: August 8, 2017
    Assignee: OPENCELL TECHNOLOGIES, INC.
    Inventors: John Mark Meacham, Kiranmai Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta
  • Publication number: 20140273229
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Inventors: John Mark Meacham, Kiran Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta